Parmax Pharma Share Price History and Returns 2017 to 2024
Parmax Pharma Limited | |||
 | Symbol: PARMAX | ||
| Price: ₹48.98 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Parmax Pharma Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Parmax Pharma Recent Performance
- 3: Parmax Pharma Stock Price Chart From 2017 to 2024
- 4: Parmax Pharma Stock Price History Table From 2017 to 2024
- 5: Analyzing the Impact of Investing in Parmax Pharma
- 5.1: Parmax Pharma Stock Returns In Last 5 Years
- 5.2: Parmax Pharma Stock VS FD (Normal) VS FD (Compounding)
Parmax Pharma Stock Highlights
As of Tue 19 Nov 2024, Parmax Pharma Stock price is ₹48.98 which is ₹5.02 below 52-week high of ₹54 and ₹24.80 above 52-week low of ₹24.18
52-Week High Low
- Parmax Pharma 52-Week High is ₹54 occured on Fri 27 Sep 2024
- Parmax Pharma 52-Week Low is ₹24.18 occured on Wed 13 Mar 2024
All Time High
- The all-time high or the highest price that Parmax Pharma stocks have ever touched was ₹81.9 and this occurred on Tue 01 Jun 2021.
- The highest closing price at which Parmax Pharma stocks have ever closed was ₹62.7 recorded on Tue 01 Jun 2021.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Parmax Pharma Recent Performance
Over the past 20 trading days, the value of Parmax Pharma's stock has increased by ₹5.93 (+13.77%). On 17 Oct 2024, its one share was worth ₹43.05 and by 19 Nov 2024, the value jumped to ₹48.98. During this period it created a highest high of ₹50.63 and lowest low of ₹40.00.
Below Image represents line chart of daily close price of Parmax Pharma, helping you visualize how the price has changed day by day.
Parmax Pharma Stock Price Chart From 2017 to 2024
Parmax Pharma Stock Price History Table From 2017 to 2024
| Year | Parmax Pharma | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2017 | ₹17.00 | - | ↑ ₹17.00 ↓ ₹12.50 |
| 2018 | ₹17.30 | 1.7% | ↑ ₹21.25 ↓ ₹17.00 |
| 2019 | ₹18.00 | 4% | ↑ ₹19.95 ↓ ₹17.30 |
| 2020 | ₹29.50 | 63.8% | ↑ ₹52.05 ↓ ₹15.20 |
| 2021 | ₹59.95 | 103.2% | ↑ ₹81.90 ↓ ₹24.25 |
| 2022 | ₹38.70 | -35.5% | ↑ ₹63.50 ↓ ₹26.35 |
| 2023 | ₹32.57 | -15.9% | ↑ ₹40.95 ↓ ₹27.00 |
| 2024 | ₹48.98 | 50.3% | ↑ ₹49.00 ↓ ₹45.14 |
Analyzing the Impact of Investing in Parmax Pharma
Parmax Pharma Stock price in the year 2017 was ₹17.00. If you had invested ₹10,000 in Parmax Pharma Stock in 2017, in 7 years, your investment would have grown to ₹28,811 by the end of 2024. This represents a positive return of 188% from 2017 to 2024, with a compound annual growth rate (CAGR) of 16.3%.
Parmax Pharma Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: 81.90 and lowest was: 15.20
- Parmax Pharma Stock price in 2019 was 18.00
- By 2024, its stock price rose to 48.98
- It gave a positive return of over 172% with a CAGR of 22.1% over the last 5 years
- If you had invested 10,000 in Parmax Pharma in 2019 then in 5 years, your investment would have grown to 27,211 by 2024, which is 2.72 times of your initial investment.
Parmax Pharma Stock VS FD (Normal) VS FD (Compounding)
You might wonder which option is better: Parmax Pharma stocks, fixed deposits (FDs) or compounding FDs. Let’s compare them and see how they differ.To help you make a well-informed decision, we have prepared a handy table that compares the returns of Parmax Pharma Stock with both FD choices over time.
If you invested ₹10,000 each in these 3 options in null:
| Year | Parmax Pharma Investment | FD Normal Investment | FD Compond Investment |
|---|---|---|---|
| 2017 | ₹10,000 | ₹10,000 | ₹10,000 |
Then today, your investment would have become this much in each option: | |||
| 2024 | ₹28,701.63 | ₹14,200.00 | ₹15,036.30 |
Note: The Stock price data displayed on this web page has been adjusted for any bonus Stocks or Stock splits that occurred over time.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
